Teduglutide Therapy in Short Bowel Syndrome – Intestinal Failure: A Multi-Centre Australian Real-World Observational Study
Background: International evidence supports teduglutide efficacy in reducing parenteral support (PS) requirements in short-bowel syndrome-intestinal failure (SBS-IF). This is the first multi-centre observational study presenting the Australian teduglutide real-world experience.
Authors
- Adam Testro (ORCID: https://orcid.org/0000-0001-6776-3115)
- Elizabeth Low (ORCID: https://orcid.org/0000-0002-0604-3920)
- Katrina Tan
- Brooke Chapman (ORCID: https://orcid.org/0000-0002-7251-8314)
- Darren Wong (ORCID: https://orcid.org/0000-0003-1490-0547)
- Kathryn Burrell
Institutions
- Austin Health (AU)
Publication Details
- Journal
- Intestinal failure.
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.intf.2025.100084
- Primary Topic
- Clinical Nutrition and Gastroenterology
- Type
- article
- Field-Weighted Citation Impact
- 0.00